[1]
2024. Tirzepatide and the Weight-Regain Question: A Narrative Review of What Happens When Treatment Stops. Journal of Clinical Diabetes and Obesity. 4, 1 (Sep. 2024), 1–6. DOI:https://doi.org/10.5281/zenodo.22260596.